INFLUENCE OF SELECTIVE ALPHA(2)-ADRENERGIC AGENTS ON MUSTARD OIL-INDUCED CENTRAL HYPERALGESIA IN RATS

被引:24
作者
MANSIKKA, H
PERTOVAARA, A
机构
[1] UNIV HELSINKI, DEPT PHYSIOL, SF-00014 HELSINKI, FINLAND
[2] UNIV TURKU, DEPT PHYSIOL, SF-20500 TURKU, FINLAND
基金
芬兰科学院;
关键词
NEUROPATHY; HYPERALGESIA; MEDETOMIDINE; ATIPAMEZOLE; MUSTARD OIL;
D O I
10.1016/0014-2999(95)00227-C
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of systemically administered medetomidine, an alpha(2)-adrenoceptor agonist, and atipamezole, an alpha(2)-adrenoceptor antagonist, on mustard oil-induced central hyperalgesia were determined in unanesthetized rats. The mechanical threshold for eliciting a hindlimb flexion reflex (a nocifensive response) was determined with a series of calibrated monofilaments. Under control conditions mustard oil produced a significant decrease of the hindlimb withdrawal threshold for mechanical stimuli applied to a distal site in the hindlimb, whereas the corresponding threshold in the (untreated) contralateral side was not changed. Medetomidine administered 12 min prior to mustard oil treatment produced a significant dose-dependent (3-30 mu g/kg s.c.) attenuation of the mustard oil-induced threshold decrease whereas the withdrawal threshold of the contralateral (untreated) hindlimb was not changed at these low doses. The antinociceptive effect of medetomidine (10 mu g/kg) administered 12 min prior to the mustard oil treatment was not significantly stronger than the effect of medetomidine administered immediately after the mustard oil treatment. Atipamezole at a high (1000 mu g/kg) or a low (10 mu g/kg) dose did not influence the mustard oil-induced threshold decrease, whereas at an intermediate dose (100 mu g/kg) atipamezole alone had a significant antinociceptive effect on mustard oil-induced hyperalgesia. The results indicate that medetomidine produces a selective attenuation of central hyperalgesia at doses which are sub-antinociceptive in intact rats. A pre-emptive treatment with medetomidine did not produce stronger antinociception than medetomidine treatment after the development of hyperalgesia. An alpha-adrenoceptor antagonist, atipamezole, attenuated central hyperalgesia in a non-monotonic fashion.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 29 条
[1]   RECEPTOR CHANGES IN THE SPINAL-CORD OF SHEEP ASSOCIATED WITH EXPOSURE TO CHRONIC PAIN [J].
BRANDT, SA ;
LIVINGSTON, A .
PAIN, 1990, 42 (03) :323-329
[2]   QUANTITATIVE ASSESSMENT OF TACTILE ALLODYNIA IN THE RAT PAW [J].
CHAPLAN, SR ;
BACH, FW ;
POGREL, JW ;
CHUNG, JM ;
YAKSH, TL .
JOURNAL OF NEUROSCIENCE METHODS, 1994, 53 (01) :55-63
[3]   HEAT AND MECHANICAL HYPERALGESIA INDUCED BY CAPSAICIN - CROSS MODALITY THRESHOLD MODULATION IN HUMAN C-NOCICEPTORS [J].
CULP, WJ ;
OCHOA, J ;
CLINE, M ;
DOTSON, R .
BRAIN, 1989, 112 :1317-1331
[4]   PAIN MODULATION BY ADRENERGIC AGENTS AND MORPHINE AS MEASURED BY 3 PAIN TESTS [J].
DENNIS, SG ;
MELZACK, R ;
GUTMAN, S ;
BOUCHER, F .
LIFE SCIENCES, 1980, 26 (15) :1247-1259
[5]   DIFFERENTIAL INFLUENCE OF LOCAL-ANESTHETIC UPON 2 MODELS OF EXPERIMENTALLY INDUCED PERIPHERAL MONONEUROPATHY IN THE RAT [J].
DOUGHERTY, PM ;
GARRISON, CJ ;
CARLTON, SM .
BRAIN RESEARCH, 1992, 570 (1-2) :109-115
[6]   CAPSAICIN-INDUCED CENTRAL FACILITATION OF A NOCICEPTIVE FLEXION REFLEX IN HUMANS [J].
GRONROOS, M ;
PERTOVAARA, A .
NEUROSCIENCE LETTERS, 1993, 159 (1-2) :215-218
[7]   ANTAGONISM OF ALPHA-ADRENOCEPTOR AGONIST-INDUCED ANTINOCICEPTION IN THE RAT [J].
HAYES, AG ;
SKINGLE, M ;
TYERS, MB .
NEUROPHARMACOLOGY, 1986, 25 (04) :397-402
[8]   SPINAL OPIOID ANALGESIC EFFECTS ARE ENHANCED IN A MODEL OF UNILATERAL INFLAMMATION HYPERALGESIA - POSSIBLE INVOLVEMENT OF NORADRENERGIC MECHANISMS [J].
HYLDEN, JLK ;
THOMAS, DA ;
IADAROLA, MJ ;
NAHIN, RL ;
DUBNER, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 194 (2-3) :135-143
[9]  
IDANPAANHEIKKILA JJ, 1994, J PHARMACOL EXP THER, V271, P1306
[10]   ANTINOCICEPTIVE EFFECTS OF INTRATHECAL ADMINISTRATION OF ALPHA-ADRENOCEPTOR ANTAGONISTS AND CLONIDINE IN THE FORMALIN TEST IN THE MOUSE [J].
KANUI, TI ;
TJOLSEN, A ;
LUND, A ;
MJELLEMJOLY, N ;
HOLE, K .
NEUROPHARMACOLOGY, 1993, 32 (04) :367-371